Simplex Trading’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$108 Sell
200
-11,500
-98% -$8.46K ﹤0.01% 8871
2025
Q4
$9.25K Buy
11,700
+2,200
+23% +$2.16K ﹤0.01% 7033
2025
Q3
$9K Buy
+9,500
New +$9.98K ﹤0.01% 7990
2023
Q1
Sell
-1,460
Closed -$7K 10143
2022
Q4
$7K Sell
1,460
-200
-12% -$1.21K ﹤0.01% 7858
2022
Q3
$8K Sell
1,660
-5,000
-75% -$32.2K ﹤0.01% 8449
2022
Q2
$40K Sell
6,660
-480
-7% -$2.93K ﹤0.01% 6780
2022
Q1
$37K Buy
7,140
+5,020
+237% +$28.9K ﹤0.01% 7551
2021
Q4
$15K Sell
2,120
-620
-23% -$5.86K ﹤0.01% 8705
2021
Q3
$40K Hold
2,740
﹤0.01% 7800
2021
Q2
$40K Buy
2,740
+2,730
+27,300% +$45.4K ﹤0.01% 7929
2021
Q1
$18K Sell
10
-22
-69% -$529 ﹤0.01% 7551
2020
Q4
$61K Buy
32
+10
+45% +$165 ﹤0.01% 5974
2020
Q3
$22K Sell
22
-7
-24% -$81 ﹤0.01% 6307
2020
Q2
$31K Buy
29
+21
+263% +$160 ﹤0.01% 5899
2020
Q1
$4K Buy
+8
New +$42 ﹤0.01% 6982
2016
Q1
Sell
-2
Closed -$2K 6258
2015
Q4
$2K Buy
+2
New +$118 ﹤0.01% 4597

Other funds holding TRIB

Simplex Trading's TRIB Position: Q1 2026 in Review

Simplex Trading opened a new position in Trinity Biotech (TRIB) in Q1 2026: 555 shares worth $300. The stake represents ﹤0.01% of the portfolio and ranks #8797 among its holdings. This is a return to the name: Simplex Trading previously reported a position in TRIB as recently as Q3 2025.

Simplex Trading first reported a position in TRIB in Q4 2014 and has held it in 20 quarters since. The position peaked at $28K in Q1 2021. 23 funds tracked by Wall St. Rank hold TRIB as of Q1 2026.

  • Simplex Trading held 555 shares of Trinity Biotech worth $300 as of Q1 2026.
  • Trinity Biotech was a new Simplex Trading position in Q1 2026.
  • Trinity Biotech made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8797 holding.
  • Simplex Trading first reported a position in Trinity Biotech in Q4 2014 and has held it in 20 quarters since.
  • Simplex Trading's Trinity Biotech position peaked at $28K in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.